Kann Ipamorelin zur Gewichtsabnahme verwendet werden
Our editorial recommendations are based on research, product quality, performance, and value
More research is needed to investigate and evaluate the role of GLP-1-based medications as a treatment and preventative therapy for obesity and autoimmune disease
The slowdown came fast, steadily, and relentlessly, as seen in Intuitives subsequent quarterly commentary: Q323: In bariatrics, we continued to see double digit growth albeit at a modestly lower growth rate compared to Q2 Q423: We saw a continued deceleration in growth throughout 2023, likely the result of the uptake of GLP-1 drugs. Q124: Bariatric procedure growth continued to moderate and was flat year-over-year
After 28 weeks, berobenatide demonstrated placebo-adjusted weight loss of up to 12.3% with the 4.8 mg monthly dose
This approach maximizes weight loss results, minimizes side effects, and provides a safer, more sustainable path to long-term success